Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Revolution Medicines, Inc.(RVMD) | 2,577,333 | 2,577,333 | 0 | $250.65M | $482.68M | 24.16% | +$232.04M |
| Relay Therapeutics, Inc.(RLAY) | 14,418,574 | 16,035,240 | +1,616,666 | $143.46M | $300.02M | 15.02% | +$156.55M |
| GeneDx Holdings Corp.CL A(WGS) | 3,007,164 | 3,707,164 | +700,000 | $193.12M | $254.50M | 12.74% | +$61.38M |
| Biolife Solutions Inc | 5,957,165 | 4,655,000 | -1,302,165 | $113.66M | $131.46M | 6.58% | +$17.79M |
| Illumina, Inc.(ILMN) | 530,000 | 530,000 | 0 | $65.33M | $93.19M | 4.66% | +$27.86M |
| Standard BioTools Inc.(LAB) | 88,783,856 | 88,783,856 | 0 | $81.62M | $73.04M | 3.66% | -$8.58M |
| Structure Therapeutics IncADS | 1,175,000 | 1,175,000 | 0 | $56.63M | $63.06M | 3.16% | +$6.43M |
| Denali Therapeutics Inc.(DNLI) | 1,840,000 | 2,045,000 | +205,000 | $35.33M | $52.60M | 2.63% | +$17.27M |
| Neurogene Inc.(NGNE) | 1,420,361 | 1,545,361 | +125,000 | $28.63M | $48.60M | 2.43% | +$19.97M |
| Beam Therapeutics Inc.(BEAM) | 1,350,000 | 1,350,000 | 0 | $32.17M | $46.33M | 2.32% | +$14.16M |
| 10x Genomics, Inc.CL A(TXG) | 2,275,000 | 1,050,000 | -1,225,000 | $48.30M | $40.26M | 2.02% | -$8.04M |
| Scholar Rock Holding Corporation(SRRK) | 350,000 | 665,000 | +315,000 | $17.21M | $36.58M | 1.83% | +$19.37M |
| Personalis, Inc.(PSNL) | 1,600,000 | 2,550,000 | +950,000 | $10.19M | $34.17M | 1.71% | +$23.98M |
| GRAIL, Inc.(GRAL) | 230,000 | 480,000 | +250,000 | $11.89M | $32.77M | 1.64% | +$20.88M |
| Guardant Health, Inc.(GH) | 315,000 | 185,000 | -130,000 | $29.10M | $27.76M | 1.39% | -$1.34M |
| Maze Therapeutics, Inc.(MAZE) | 758,857 | 843,857 | +85,000 | $22.65M | $25.18M | 1.26% | +$2.53M |
| Hims & Hers Health, Inc.CL A(HIMS) | 700,000 | 700,000 | 0 | $14.53M | $24.27M | 1.21% | +$9.74M |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 75,000 | 75,000 | 0 | $24.82M | $22.58M | 1.13% | -$2.24M |
| Taysha Gene Therapies, Inc.(TSHA) | 3,250,000 | 3,250,000 | 0 | $14.53M | $22.13M | 1.11% | +$7.61M |
| AgomAb Therapeutics NVADS(AGMB) | 1,550,000 | 1,550,000 | 0 | $16.26M | $20.12M | 1.01% | +$3.86M |
| Septerna, Inc.(SEPN) | 553,268 | 553,268 | 0 | $13.30M | $18.53M | 0.93% | +$5.23M |
| Parabilis Medicines Inc | 0 | 645,690 | +645,690 | $0 | $17.67M | 0.88% | +$17.67M |
| Sionna Therapeutics, Inc.(SION) | 0 | 400,000 | +400,000 | $0 | $17.60M | 0.88% | +$17.60M |
| Veracyte, Inc.(VCYT) | 276,308 | 276,308 | 0 | $8.90M | $16.23M | 0.81% | +$7.33M |
| Adlai Nortye Group Ltd.ADS(ANL) | 538,461 | 1,250,000 | +711,539 | $3.73M | $14.38M | 0.72% | +$10.65M |
| Prime Medicine, Inc.(PRME) | 3,167,175 | 3,167,175 | 0 | $11.02M | $11.69M | 0.58% | +$665.1K |
| Absci Corporation | 973,260 | 973,260 | 0 | $2.92M | $11.28M | 0.56% | +$8.36M |
| Quest Diagnostics Incorporated(DGX) | 50,000 | 50,000 | 0 | $9.80M | $10.60M | 0.53% | +$798.5K |
| Sarepta Therapeutics, Inc.(SRPT) | 0 | 470,000 | +470,000 | $0 | $8.45M | 0.42% | +$8.45M |
| uniQure N.V.SHS(QURE) | 0 | 150,000 | +150,000 | $0 | $6.91M | 0.35% | +$6.91M |
| Intellia Therapeutics, Inc.(NTLA) | 355,000 | 355,000 | 0 | $4.55M | $6.01M | 0.30% | +$1.46M |
| Moderna, Inc.(MRNA) | 75,000 | 75,000 | 0 | $3.81M | $5.25M | 0.26% | +$1.44M |
| Disc Medicine, Inc.(IRON) | 65,000 | 65,000 | 0 | $4.16M | $4.75M | 0.24% | +$598.0K |
| Monte Rosa Therapeutics, Inc.(GLUE) | 186,014 | 186,014 | 0 | $3.06M | $4.50M | 0.23% | +$1.44M |
| Century Therapeutics, Inc.(IPSC) | 1,228,190 | 1,228,190 | 0 | $2.78M | $3.01M | 0.15% | +$233.4K |
| Contineum Therapeutics, Inc.CL A(CTNM) | 148,333 | 148,333 | 0 | $1.94M | $2.43M | 0.12% | +$493.9K |
| BridgeBio Oncology Therapeutics, Inc.(BBOT) | 282,312 | 282,312 | 0 | $2.53M | $2.15M | 0.11% | -$375.5K |
| Editas Medicine, Inc.(EDIT) | 0 | 445,000 | +445,000 | $0 | $1.44M | 0.07% | +$1.44M |
| Pacific Biosciences of California, Inc.(PACB) | 723,767 | 723,767 | 0 | $955.4K | $1.22M | 0.06% | +$260.6K |
| Kardigan Inc | 0 | 50,000 | +50,000 | $0 | $1.19M | 0.06% | +$1.19M |
| Recursion Pharmaceuticals, Inc.CL A(RXRX) | 165,323 | 165,323 | 0 | $507.5K | $606.7K | 0.03% | +$99.2K |
| Ginkgo Bioworks Holdings, Inc.CL A(DNA) | 36,493 | 36,493 | 0 | $223.7K | $361.6K | 0.02% | +$137.9K |
| Tenaya Therapeutics, Inc.(TNYA) | 361,969 | 361,969 | 0 | $250.6K | $267.5K | 0.01% | +$16.9K |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 450,000 | 0 | -450,000 | $8.39M | $0 | — | -$8.39M |
| Qiagen N.V.(QGEN) | 360,000 | 0 | -360,000 | $14.41M | $0 | — | -$14.41M |
| Tempus AI, Inc.CL A(TEM) | 294,127 | 0 | -294,127 | $13.30M | $0 | — | -$13.30M |